Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Renna

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
Journal of Crohn'S & Colitis|December 3, 2010
Regional variations in the use of complementary and alternative medicines (CAM) for inflammatory bowel disease patients in Italy: an IG-IBD studyPerla Bertomoro, Sara Renna, Mario Cottone, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 20, 2022
The effectiveness of ustekinumab and vedolizumab as third-line biologic therapy in patients with Crohn's diseaseFabio Salvatore Macaluso, Mauro Grova, Marica Saladino, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 1, 2016
Six year adalimumab efficacy in steroid-dependent Crohn's disease patients: A prospective single-center real life studyAmbrogio Orlando, Sara Renna, Filippo Mocciaro, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 26, 2018
Outcome in ulcerative colitis after switch from adalimumab/golimumab to infliximab: A multicenter retrospective studyAnna Viola, Daniela Pugliese, Sara Renna, et al.
Journal of Clinical Medicine|April 13, 2024
Immune-Mediated Inflammatory Diseases Awareness and Management among Physicians Treating Patients with Inflammatory Bowel Disease: An IG-IBD SurveyMarta Vernero, Cristina Bezzio, Davide G Ribaldone, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 14, 2021
Female reproductive health and inflammatory bowel disease: A practice-based review, Alessandro Armuzzi, Aurora Bortoli, et al.
Journal of Crohn'S & Colitis|July 17, 2020
Dual Targeted Therapy: a possible option for the management of refractory Inflammatory Bowel DiseaseGiuseppe Privitera, Sara Onali, Daniela Pugliese, et al.
European Journal of Gastroenterology & Hepatology|June 23, 2009
Internet use among inflammatory bowel disease patients: an Italian multicenter surveyErika Angelucci, Ambrogio Orlando, Sandro Ardizzone, et al.
Expert Opinion on Biological Therapy|September 15, 2021
One-year effectiveness and safety of ustekinumab in ulcerative colitis: a multicenter real-world study from ItalyMichele Francesco Chiappetta, Anna Viola, Mauro Mastronardi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 27, 2018
The real-world effectiveness of vedolizumab on intestinal and articular outcomes in inflammatory bowel diseasesFabio Salvatore Macaluso, Rosalba Orlando, Walter Fries, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Journal of Crohn'S & Colitis|December 3, 2010
Regional variations in the use of complementary and alternative medicines (CAM) for inflammatory bowel disease patients in Italy: an IG-IBD studyPerla Bertomoro, Sara Renna, Mario Cottone, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 20, 2022
The effectiveness of ustekinumab and vedolizumab as third-line biologic therapy in patients with Crohn's diseaseFabio Salvatore Macaluso, Mauro Grova, Marica Saladino, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 1, 2016
Six year adalimumab efficacy in steroid-dependent Crohn's disease patients: A prospective single-center real life studyAmbrogio Orlando, Sara Renna, Filippo Mocciaro, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 26, 2018
Outcome in ulcerative colitis after switch from adalimumab/golimumab to infliximab: A multicenter retrospective studyAnna Viola, Daniela Pugliese, Sara Renna, et al.
Journal of Clinical Medicine|April 13, 2024
Immune-Mediated Inflammatory Diseases Awareness and Management among Physicians Treating Patients with Inflammatory Bowel Disease: An IG-IBD SurveyMarta Vernero, Cristina Bezzio, Davide G Ribaldone, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 14, 2021
Female reproductive health and inflammatory bowel disease: A practice-based review, Alessandro Armuzzi, Aurora Bortoli, et al.
Journal of Crohn'S & Colitis|July 17, 2020
Dual Targeted Therapy: a possible option for the management of refractory Inflammatory Bowel DiseaseGiuseppe Privitera, Sara Onali, Daniela Pugliese, et al.
European Journal of Gastroenterology & Hepatology|June 23, 2009
Internet use among inflammatory bowel disease patients: an Italian multicenter surveyErika Angelucci, Ambrogio Orlando, Sandro Ardizzone, et al.
Expert Opinion on Biological Therapy|September 15, 2021
One-year effectiveness and safety of ustekinumab in ulcerative colitis: a multicenter real-world study from ItalyMichele Francesco Chiappetta, Anna Viola, Mauro Mastronardi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 27, 2018
The real-world effectiveness of vedolizumab on intestinal and articular outcomes in inflammatory bowel diseasesFabio Salvatore Macaluso, Rosalba Orlando, Walter Fries, et al.
Pageof 7